+86-826-5999982
sales@taienkangpharma.com
四川泰恩康制药有限公司
Home
About Us
Company Profile
Milestones
Video Center
Corporate Culture
Products & Services
APIs
Intermediates
CDMO
Infrastructure
RnD & Innovation
Manufacturing Site
News
Company News
Contact Us
NEWS
2023
Establish strategic partnership with Jiangsu BCY pharm as Taienkang’s 3rd R&D center.
2023-11-02
11-02
2022
Stock-list on the GEM of Shenzhen Stock Exchange with the stock code 301263.
2020
Establish Sichuan Taienkang Pharmaceutical Co., Ltd.
Oct. 2015
Establish the R&D company Shandong Hubble Kisen Biological Technology Co., Ltd.
Feb. 2015
Acquire Anhui Taienkang Pharmaceutical Co., Ltd.
2011~2014
Complete the company’s listing reorganization and shareholding system reformation. In 2014, stock-list on the Chinese “New Third Board”.
2009
Aquire “Shantou Wuhan Pharmaceutical Factory” and rename it as “Guangdong Taienkang Pharmaceutical Factory Co., Ltd.” Enter the business sector of pharmaceutical manufacturing.
2002
Establish Shantou Taienkang Medical Equipment Co., Ltd., and expand the business to medical equipments,hygienic materials and pharmaceutical products. Establish corporate partnerships with Johnson & Johnson, Abbott Laboratories, etc.
1999
Establish Shantou Taikang Pharmaceutical Co., Ltd and start the business as the exclusive distributor for “Fishing Pill IV” from Thailand and “Lodized Lecithin Tablets”from Japan.